Levi & Korsinsky notifies investors that it has commenced an investigation into GSK plc (NYSE: GSK) concerning potential violations of the federal securities laws.
GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of Blenrep (belantamab mafodotin-blmf) combinations." Following this news, GSK's American Depositary Receipt ("ADR") price fell over 4% on July 17, 2025.
If you suffered a loss on your GSK plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Exelixis, Inc. (NASDAQ: EXEL) concerning potential violations of the federal securities laws.
Exelixis issued a press release on July 28, 2025, "report[ing] financial results for the second quarter of 2025" and "provid[ing] an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and pipeline development milestones." Among other items, Exelixis reported that net product revenues for cabozantinib were approximately 2% below the consensus estimate of $531.3 million. Exelixis also disclosed that "[b]ased on our evaluation of emerging data from the phase 2 portion of the STELLAR-305 study in advanced squamous cell carcinoma of the head and neck, emerging competition in this indication and assessment of other potentially larger commercial opportunities, we have made the decision not to proceed to the phase 3 portion of the trial." Following this news, Exelixis's stock price fell over 16% on July 29, 2025.
If you suffered a loss on your Exelixis, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Teva Pharmaceutical Industries Limited (NYSE: TEVA) concerning potential violations of the federal securities laws.
On July 31, 2025, Teva published a press release reporting the Company’s second quarter 2025 financial results. As part of the press release, Teva disclosed that generic product revenues were down. The Company’s management predicted a flat year for generic revenue globally, blaming the delay of certain generic launches. Following this news, Teva’s stock price fell over 8.2% to close at $15.45 per share on July 31, 2025.
If you suffered a loss on your Teva Pharmaceutical Industries Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Duolingo, Inc. (NASDAQ: DUOL) concerning potential violations of the federal securities laws.
On July 28, 2025, JMP Securities lowered its price target on Duolingo stock to $450 from $475, citing concerns about slowing user engagement ahead of the Company's second-quarter earnings report. Specifically, third party data suggested that daily active user growth decelerated to approximately 39% year-over-year in the second quarter, a noticeable drop from about 51% in the first quarter. Following this news, Duolingo's stock price fell over 6% on the same day.
If you suffered a loss on your Duolingo, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Fomento Econmico Mexicano, S.A.B. de C.V. (NYSE: FMX) concerning potential violations of the federal securities laws.
On July 28, 2025, Fomento issued a press release announcing their second quarter fiscal 2025 results well-below expectations with profit falling 60% year-over-year, resulting in earnings of only $0.40 per share. During the earnings call, management disclosed that despite growing revenue more than 6%, operating income increased only 0.2% since last year. Fomento put the blame on a “challenging consumer environment in Mexico” but also admitted that their “operations were geared to a stronger consumer environment [in Mexico] than the one that materialize, plus our cost and expenses ran a bit ahead of actual volume and traffic.” Following this news, Fomento’s stock price fell by $6.35 per share and is currently trading at $92.25 per share.
If you suffered a loss on your Fomento Econmico Mexicano, S.A.B. de C.V. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into ZEEKR Intelligent Technology Holding Limited (NYSE: ZK) concerning potential violations of the federal securities laws.
Reuters published an article on July 19, 2025, reporting that "Chinese electric vehicle brands Neta and Zeekr inflated sales in recent years to hit aggressive targets," citing "documents reviewed by Reuters and interviews with dealers and buyers." The article reported that "[t]he companies arranged for cars to be insured before they were sold to buyers, . . . enabling them under Chinese industry car registration practices to book sales early so they could hit the monthly and quarterly targets[.]" Following this news, Zeekr's American Depositary Receipt ("ADR") fell over 3% on July 21, 2025.
If you suffered a loss on your ZEEKR Intelligent Technology Holding Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Whirlpool Corporation (NYSE: WHR) concerning potential violations of the federal securities laws.
On July 29, 2025, Whirlpool issued a press release announcing positive second quarter results, featuring “sequential net sales growth across all segments” despite that “the second quarter continued to be impacted by competitors stockpiling Asian imports into the US.” Whirlpool further announced it would be considerably reducing its full-year guide due to the same continued impact from Asian importers and the general continued impact from the ongoing “uncertainty in the macro environment.” Full-year earnings were cut 30% at the midpoint with management now anticipating only $6 - $8 per share, down from $10. Management also informed investors during the call it would recommend the Board cut the company’s annual dividend by nearly 50%, down to $3.60 from $7. Following this news, Whirlpool’s stock price fell by $13.58 per share to open at $84.39 per share.
If you suffered a loss on your Whirlpool Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Barnes & Noble Education, Inc. (NYSE: BNED) concerning potential violations of the federal securities laws.
Barnes & Noble disclosed in a filing on July 18, 2025, with the U.S. Securities and Exchange Commission that its annual report for the fiscal year ended May 3, 2025 will be delayed due to an ongoing investigation regarding how the costs of digital sales were recorded. The investigation's early findings indicate that Barnes & Noble may have overstate accounts receivable by up to $23 million, and that the Company expects to report at least one material weakness tied to manual journal entries. Following this news, Barnes & Noble's stock price fell over 21% on July 21, 2025.
If you suffered a loss on your Barnes & Noble Education, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into MarineMax, Inc. (NYSE: HZO) concerning potential violations of the federal securities laws.
MarineMax issued a press release on July 24, 2025, reporting its financial results for the third quarter of 2025. Among other items, MarineMax cut its profit guidance by half at the midpoint to $0.45 to $0.95 per share, compared to prior guidance of $1.40 to $2.40 per share. MarineMax's Chief Executive Officer stated that "[a] combination of ongoing economic uncertainty, evolving trade policies and geopolitical tensions contributed to weak retail demand across the recreational marine industry in the June quarter," adding that the challenging business conditions is leading consumers to delay purchases until conditions improve. Following this news, MarineMax's stock price fell over 16% on July 24, 2025.
If you suffered a loss on your MarineMax, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Geely Automobile Holdings Limited (OTC: GELYY) concerning potential violations of the federal securities laws.
Reuters published an article on July 19, 2025, reporting that Geely's premium electric vehicle brand "Zeekr inflated sales in recent years to hit aggressive targets," citing "documents reviewed by Reuters and interviews with dealers and buyers." The article reported that Zeekr "arranged for cars to be insured before they were sold to buyers, . . . enabling them under Chinese industry car registration practices to book sales early so they could hit the monthly and quarterly targets[.]" Following this news, the value of Geely securities fell sharply.
If you suffered a loss on your Geely Automobile Holdings Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Otis Worldwide Corporation (NYSE: OTIS) concerning potential violations of the federal securities laws.
On July 23, 2025, Otis reported its second quarter fiscal 2025 earnings, unveiling net sales for the quarter of $3.6 billion that fell below analysts’ expectations for $3.71 billion. Management noted that new-equipment sales declined 10%, worse than the market feared, in the quarter, triggering the company to reduce their annual guidance from $14.6 – $14.8 billion down to $14.5 – $14.6 billion in the second quarter. While the Company largely blamed the setback on challenges in China, in which new equipment sales fell 20% in the quarter, declines were also seen in the Americas and Asia Pacific. Following this news, Otis’ stock price fell by $12.79 per share to open at $88.20 per share.
If you suffered a loss on your Otis Worldwide Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Encompass Health Corporation (NYSE: EHC) concerning potential violations of the federal securities laws.
On July 15, 2025, the New York Times published an article, entitled “Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed,” discussing the state of the private rehabilitation hospital industry. In the article, the Times specifically identified Encompass as one of the for-profit rehab corporations that “have had rare but serious incident of patient harm and perform below average on two key safety measure tracked by Medicare.” The article went on to note specific examples highlighting significant patient safety concerns, medication errors, and an overall lack of oversight at Encompass’ hospitals. Following this news, Encompass’ stock price fell by $12.39 per share to close at $ 107.28 per share.
If you suffered a loss on your Encompass Health Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Simulations Plus, Inc. (NASDAQ: SLP) concerning potential violations of the federal securities laws.
Simulations Plus reported its financial results for its third fiscal quarter on July 14, 2025. Among other items, Simulations Plus reported sales of $20.4 million, missing the consensus estimate of $20.9 million. Simulations Plus also reported a net loss of $67.3 million and diluted loss per share of $3.35, reflecting a non-cash impairment charge of $77.2 million, compared to net income of $3.1 million and diluted earnings per share of $0.15 for the same period in 2024. The Company also revised its fiscal 2025 adjusted earnings guidance to $0.93 to $1.06, down from the previous guidance of $1.07 to $1.20. Simulations Plus advised investors that, in June, the Company had initiated a restructuring of its operations, including workforce reductions and cost-cutting measures, aimed at improving operational efficiency and reducing expenses. Following this news, Simulations Plus's stock price fell over 25% on July 15, 2025.
If you suffered a loss on your Simulations Plus, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Bruker Corporation (NASDAQ: BRKR) concerning potential violations of the federal securities laws.
On July 21, 2025, Bruker announced disappointing preliminary results for the second quarter, ended June 30, 2025. The Company disclosed earnings and revenue that both fell well-below expectations and announced an estimated 7% year-over-year organic revenue decline, significantly worse than management previously forecast. Bruker blamed soft demand from academic institutions and a slowdown in biopharma for the weakness in bookings, despite having last quarter “established a floor based on current headwinds” including concerns around academic uncertainty and the threat of biopharma tariffs. Following this news, Bruker’s stock price fell by $3.74 per share to open at $36.82 per share.
If you suffered a loss on your Bruker Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc (NASDAQ: MREO) concerning potential violations of the federal securities laws.
Mereo and its development partner Ultragenyx Pharmaceutical Inc. issued a press release on July 9, 2025, "announcing that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis[.]" Following a Data Monitoring Committee meeting, the two companies advised that the final analysis would occur "around the end of the year." Following this news, Mereo's American Depositary Receipt ("ADR") price fell over 42% on July 10, 2025.
If you suffered a loss on your Mereo BioPharma Group plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) concerning potential violations of the federal securities laws.
On July 9, 2025, Ultragenyx issued a press release announcing the randomized controlled portion of the Phase 3 Orbit Study for Osteogenesis Imperfecta is progressing toward final analysts for end of year but stopped short of presenting any interim results. Ultragenyx had “hoped to be able to stop the study early” if positive results were achieved at the interim analysis. Following this news, Ultragenyx’s stock price fell by $10.83 per share to open at $30.61 per share.
If you suffered a loss on your Ultragenyx Pharmaceutical Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Jasper Therapeutics, Inc. (NASDAQ: JSPR) concerning potential violations of the federal securities laws.
Jasper issued a press release on July 7, 2025, "reporting updated data from Company's BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with CSU and providing an update on the program." The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question. The Company is investigating the drug product lot in question and expects to have the results of that investigation in the coming weeks." Following this news, Jasper's stock price fell over 55% on July 7, 2025.
If you suffered a loss on your Jasper Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Funko, Inc. (NASDAQ: FNKO) concerning potential violations of the federal securities laws.
On July 7, 2025, Funko announced the departure of Cynthia Williams as its Chief Executive Officer, effective July 5, 2025. Following this news, Funko's stock price fell over 10% on the same day.
If you suffered a loss on your Funko, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into National Grid plc (NYSE: NGG) concerning potential violations of the federal securities laws.
The United Kingdom's energy system operator, National Energy System Operator ("NESO"), published a report on July 1, 2025, summarizing the findings of its investigation into the March 20, 2025 fire that caused Heathrow Airport to shut down. NESO's report stated that the fire was caused by a known fault at an electrical substation owned by National Grid, which had been aware of the problem since 2018 but failed to fix it. Media outlets subsequently reported that Heathrow Airport was considering legal action against National Grid. Following this news, National Grid's American Depositary Receipt ("ADR") price fell over 5% on July 2, 2025.
If you suffered a loss on your National Grid plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The J. M. Smucker Company (NYSE: SJM) concerning potential violations of the federal securities laws.
On June 9, 2025, Smucker announced its fourth quarter and full fiscal year 2025 financial results, highlighting increased setbacks to its Sweet Baked Snacks segment. As a result, management anticipated only 3% annual net sales growth for the segment over the long-term. The Company blamed the segment’s disappointing results on inflationary pressures, diminished income and poor execution. Following this news, SJM’s stock price fell by $17.44 per share, or approximately 16% to close at $94.41 per share.
If you suffered a loss on your The J. M. Smucker Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Harrow, Inc. (NASDAQ: HROW) concerning potential violations of the federal securities laws.
Harrow issued a press release on May 8, 2025, announcing its financial results for the first quarter of 2025. Among other items, Harrow reported revenue of $47.8 million, missing consensus estimates of $57.0 million and -$1.9 million in adjusted EBITDA, falling short of the expected $11.9 million. Following this news, Harrow's stock price fell over 4% on the same day.
If you suffered a loss on your Harrow, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into American Outdoor Brands, Inc. (NASDAQ: AOUT) concerning potential violations of the federal securities laws.
American Outdoor issued a press release on June 26, 2025, reporting its financial results for its fourth quarter and full fiscal year 2025. Among other items, American Outdoor disclosed that retailers accelerated orders in the final weeks of the quarter, effectively pulling forward an estimated $8 million to $10 million in sales from the upcoming fiscal year. American Outdoor also announced its decision to suspend its fiscal 2026 guidance, citing uncertainties around tariffs. Following this news, American Outdoor's stock price fell over 13% on June 27, 2025.
If you suffered a loss on your American Outdoor Brands, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Quantum Corporation (NASDAQ: QMCO) concerning potential violations of the federal securities laws.
Quantum disclosed that it is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 by the original due date, and that it was “reviewing its accounting related to certain revenue contracts as well as the application of standalone selling price under applicable accounting standards.” Following this news, the price of the Company’s stock dropped on June 30, 2025.
If you suffered a loss on your Quantum Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (NYSE: CTO) securities.
If you suffered a loss on your CTO Realty Growth, Inc. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: Feb 18 2021 - Jun 24 2025
CASE DETAILS: The filed complaint alleges that CTO Realty Growth, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CTO’s dividends were less sustainable than defendants had led investors to believe; (ii) the Company used deceptive and unsustainable practices to artificially inflate its adjusted funds from operations and overstate the true profitability of its Ashford Lane property; (iii) accordingly, CTO’s business and/or financial prospects were overstated; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Novo Nordisk A/S (NYSE: NVO) concerning potential violations of the federal securities laws.
Novo Nordisk announced on June 23, 2025, that it would end its partnership with Hims & Hers Health, Inc. ("Hims") to distribute its weight loss drug Wegovy, claiming that Hims "has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of ‘personalization' and are disseminating deceptive marketing that put patient safety at risk." Following this news, Novo Nordisk stock fell over 5% on the same day.
If you suffered a loss on your Novo Nordisk A/S securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Equinix, Inc. (NASDAQ: EQIX) concerning potential violations of the federal securities laws.
On June 25, 2025, during an Analyst Day event, Equinix shares plummeted as investors reacted to analyst and market sentiment that Equinix was not performing as well as competitors. Also during the event, Equinix announced that the company was experiencing unanticipated churn events and capacity constraints, which could impact pricing dynamics. Following this news, Equinix’s stock price fell over 9% to close at $824.31 per share on June 25, 2025.
If you suffered a loss on your Equinix, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into New Fortress Energy Inc. (NASDAQ: NFE) concerning potential violations of the federal securities laws.
New Fortress issued a press release on May 14, 2025, reporting its financial results for the first quarter of 2025. New Fortress disclosed weak performance across its business segments. Among other items, New Fortress reported total revenue of $470.5 million, compared to $690.3 million for the same period in 2024, as well as a net loss of $197.4 million, or $0.73 per share, compared to net income of $56.7 million, or $0.26 per share for the same period in 2024. Following this news, New Fortress's stock price fell over 62% on May 15, 2025.
If you suffered a loss on your New Fortress Energy Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Aurora Cannabis Inc. (NASDAQ: ACB) concerning potential violations of the federal securities laws.
Aurora Cannabis issued a press release on June 18, 2025, reporting its financial results for the Company's fiscal fourth quarter and full year. Among other items, Aurora Cannabis advised investors to expect temporary declines in certain of its international markets in the current quarter, while warning that its adjusted EBITDA could decline as a result of lower revenue. Following this news, Aurora Cannabis's stock price fell over 20% on June 18, 2025.
If you suffered a loss on your Aurora Cannabis Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Boeing Company (NYSE: BA) concerning potential violations of the federal securities laws.
A Boeing 787 Dreamliner aircraft operated by Air India crashed shortly after takeoff on June 12, 2025, in Ahmedabad, India. Following the crash, Boeing's stock price fell over 6% on June 13, 2025.
If you suffered a loss on your The Boeing Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Designer Brands Inc. (NYSE: DBI) concerning potential violations of the federal securities laws.
Designer Brands issued a press release on June 10, 2025, reporting its financial result for the first quarter of 2025. Among other items, Designer Brands announced its "decision to withdraw our 2025 guidance for the time being," citing "a soft start to 2025 amid an unpredictable macro environment and deteriorating consumer sentiment" and the decision to "shift[] our near-term focus to amplifying value in our retail channels, preserving margins, controlling costs, and mitigating the impact of tariffs as part of our response to this volatility." Following this news, Designer Brands' stock price fell over 18% on June 10, 2025.
If you suffered a loss on your Designer Brands Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into PetMed Express, Inc. (NASDAQ: PETS) concerning potential violations of the federal securities laws.
PetMed issued a press release on June 10, 2025, "announc[ing] it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process." Following this news, PetMed's stock price fell over 11% on June 11, 2025.
If you suffered a loss on your PetMed Express, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Dyne Therapeutics, Inc. (NASDAQ: DYN) concerning potential violations of the federal securities laws.
Dyne Therapeutics issued a press release on June 17, 2025, indicating a delay in filing for U.S. Food and Drug Administration (“FDA”) approval of DYNE-101, an experimental therapy for myotonic dystrophy type 1 (“DM1”). Following a Type C meeting with the FDA’s Center for Drug Evaluation and Research in May, the Company agreed to a revised protocol for its Phase 1/2 global ACHIEVE trial for DYNE-101 in DM1, then submitted the revised protocol to the FDA in June, incorporating changes to ACHIEVE’s ongoing Registrational Expansion Cohort. Dyne had previously set a goal to complete enrollments in the cohort in mid-2025 before generating data and submitting the regulatory submission in the first half of 2026. Under its revised schedule, however, Dyne intends to complete enrollment in the cohort in the fourth quarter of 2025, seeking a data readout in mid-2026 and a potential Accelerated Approval submission in late 2026. Following this news, Dyne’s stock price fell over 21% on June 17, 2025.
If you suffered a loss on your Dyne Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Groupon, Inc. (NASDAQ: GRPN) concerning potential violations of the federal securities laws.
The short-seller Captain's Log published a report on Groupon, on June 9, 2025, alleging that the Company has engaged in questionable accounting practices and misled investors with respect to the success of the Company's purported turnaround. Following this news, Groupon's stock price fell over 4% on June 9, 2025.
If you suffered a loss on your Groupon, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into United Natural Foods, Inc. (NYSE: UNFI) concerning potential violations of the federal securities laws.
United Natural disclosed in a filing with the U.S. Securities and Exchange Commission on June 9, 2025, that after it "became aware of unauthorized activity on certain of its Information Technology (IT) systems," it "promptly activated its incident response plan and implemented containment measures, including proactively taking certain systems offline, which has temporarily impacted the Company's ability to fulfill and distribute customer orders." Following this news, United Natural's stock price fell over 10% on June 10, 2025.
If you suffered a loss on your United Natural Foods, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Vera Bradley, Inc. (NASDAQ: VRA) concerning potential violations of the federal securities laws.
Vera Bradley issued a press release on June 11, 2025, announcing its financial results for the first quarter of its 2026 fiscal year. In the press release, Vera Bradley's Chief Executive Officer ("CEO") Jackie Ardrey said that "[o]ur first quarter results were disappointing as top line and profitability trends from the previous several quarters continued," acknowledging that there is "significant work to be done on many fronts" to return the Company to positive growth. Vera Bradley also announced several key leadership changes, including Ardrey's departure as CEO at the end of July. Following this news, Vera Bradley's stock price fell over 19% on June 11, 2025.
If you suffered a loss on your Vera Bradley, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Gilead Sciences, Inc. (NASDAQ: GILD) concerning potential violations of the federal securities laws.
Gilead issued a press release on June 10, 2025, announcing that "[t]he U.S. Food and Drug Administration has placed a clinical hold on Gilead's HIV treatment trials of GS-1720 (an investigational integrase strand transfer inhibitor) and/or GS-4182 (an investigational capsid inhibitor)[,]" specifying that "[t]he clinical hold is due to the identification of a safety signal of decreases in CD4+T-cell (CD4) and absolute lymphocyte counts in a subset of participants receiving the combination of GS-1720 and GS-4182." Following this news, Gilead's stock price fell over 2% on the same day.
If you suffered a loss on your Gilead Sciences, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Quipt Home Medical Corp. (NASDAQ: QIPT) concerning potential violations of the federal securities laws.
Forager Capital Management (“Forager”), one of Quipt’s largest shareholders, issued a press release on June 5, 2025, stating its “request[] that Quipt immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share.” Following this news, Quipt’s stock price fell over 8% on the same day.
If you suffered a loss on your Quipt Home Medical Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Hallador Energy Company (NASDAQ: HNRG) concerning potential violations of the federal securities laws.
Hallador disclosed on May 23, 2025, that its agreement with a datacenter developer that granted exclusivity in a potential power supply deal was terminated by the counterparty. Hallador said that “[t]he parties continue to discuss an additional exclusivity period and continue in non-exclusive discussions” and that the Company is also evaluating opportunities with other parties. Following this news, Hallador’s stock price fell over 7% on the same day.
If you suffered a loss on your Hallador Energy Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Abacus Global Management, Inc. (NASDAQ: ABL) concerning potential violations of the federal securities laws.
On June 4, 2025, Morpheus Research published a report alleging the company is generating fake revenue through aggressive “mark-to-model” accounting tied to its life settlements portfolio. According to the report, Abacus books revenue by marking up policies using internal life expectancy estimates that understate how long insured individuals will live. Morpheus also cites undisclosed related-party transactions and policy markups of over 80% within days of purchase. Following this news, shares of Abacus fell over 15% in intraday trading on the same day.
If you suffered a loss on your Abacus Global Management, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Descartes Systems Group Inc. (NASDAQ: DSGX) concerning potential violations of the federal securities laws.
On June 4, 2025, Descartes issued a press release announcing first quarter fiscal 2026 results, which ended below market expectations with income decreasing sequentially. As a result of the slowdown, Descartes also announced that it cut 7% of its workforce. Management blamed the disappointing results and trimmed staff on the “uncertainty in the global trade market and the economy in general.” Following this news, Descartes’ stock price fell by $11.42 per share to open at $104.23 per share.
If you suffered a loss on your The Descartes Systems Group Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Zeo Energy Corp. (NASDAQ: ZEO) concerning potential violations of the federal securities laws.
On May 29, 2025, Zeo announced receipt of "a notice . . . from Nasdaq on May 22, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the for the three months ended March 31, 2025 (the ‘10-Q') was not filed with the Securities and Exchange Commission (the ‘SEC') by the required due date of May 15, 2025." Following this news, Zeo's stock price fell over 9% on May 30, 2025.
If you suffered a loss on your Zeo Energy Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into NWTN Inc. (NASDAQ: NWTN) concerning potential violations of the federal securities laws.
NWTN disclosed receipt of a determination notice from Nasdaq on May 28, 2025, informing the Company that its securities will be delisted from Nasdaq in accordance with its listing rules. Following this news, NWTN’s stock price fell over 32%, over the following two trading sessions on May 30, 2025.
If you suffered a loss on your NWTN Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Eos Energy Enterprises, Inc. (NASDAQ: EOSE) concerning potential violations of the federal securities laws.
Eos disclosed in a filing with the U.S. Securities and Exchange Commission on May 27, 2025, that it had "terminated the employment of its Chief Financial Officer (‘CFO'), Eric Javidi, effective immediately." Eos specified that "Mr. Javidi was terminated ‘without cause' under the terms of his offer letter from the Company[.]" Following this news, Eos's stock price fell over 7% on the same day.
If you suffered a loss on your Eos Energy Enterprises, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Photronics, Inc. (NASDAQ: PLAB) concerning potential violations of the federal securities laws.
Photronics issued a press release on May 28, 2025, reporting its financial results for the second quarter of 2025. Among other items, Photronics reported revenue of $210.99 million, representing a 2.8% year-over-year decline and missing consensus estimates by $1.01 million, and non-GAAP earnings per share of $0.40, missing consensus estimates by $0.08. Photronics also issued third quarter revenue guidance in the range of $200 million to $208 million, compared to consensus estimates of $220 million. In the same press release, Photronics announced the resignation of Dr. Frank Lee from his role as the Company's Chief Executive Office, effective immediately. Following this news, Photronics' stock price fell over 15% on the same day.
If you suffered a loss on your Photronics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Tempus AI, Inc. (NASDAQ: TEM) concerning potential violations of the federal securities laws.
Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company. Among other issues, the Spruce Point report asserted that the Company used "aggressive accounting and financial reporting"; that several members of the Company's Board and "other executives have been associated with troubled companies that restated financial results"; and that "[k]ey strategic partnerships and deal announcement[s] with AstraZeneca and Pathos AI merit scrutiny." Following this news, Tempus's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Tempus AI, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into NeuroPace, Inc. (NASDAQ: NPCE) concerning potential violations of the federal securities laws.
NeuroPace issued a press release on May 27, 2025, “announc[ing] the preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for treatment of individuals with drug-resistant idiopathic generalized epilepsy (IGE).” The press release disclosed that “[t]he study did not reach statistical significance for the primary effectiveness endpoint in the overall study population, which was to show a longer time to a second generalized tonic-clonic seizure in the active stimulation group compared to the sham stimulation group.” Following this news, NeuroPace’s stock price fell over 28% on the same day.
If you suffered a loss on your NeuroPace, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Reddit, Inc. (NYSE: RDDT) securities.
If you suffered a loss on your Reddit, Inc. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: Oct 29 2024 - May 20 2025
CASE DETAILS: The filed complaint alleges that Reddit, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) changes in Google Search’s algorithm and features like AI Overview were causing users to stop their query on Google Search; (ii) these algorithm changes were materially different than prior instances of reduced traffic to the Reddit website; (iii) defendants were aware that the increase in the query term “Reddit” on search engines was because users were getting the sought after answer from Google Search without having to go to Reddit, and not because they intended to visit Reddit; (iv) this zero-click search reality was dramatically reducing traffic to Reddit in a manner the Company was unable to overcome in the short term; (v) defendants, therefore, lacked a reasonable basis for their outlook on user rates and advertising revenues; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Travere Therapeutics, Inc. (NASDAQ: TVTX) concerning potential violations of the federal securities laws.
Travere issued a press release on May 15, 2025, disclosing that the U.S. Food and Drug Administration ("FDA") "has indicated that it is currently planning to hold an advisory committee meeting to discuss" the Company's "supplemental New Drug Application (sNDA) for traditional approval of FILSPARI (sparsentan) for the treatment of focal segmental glomerulosclerosis (FSGS)." Following this news, Travere's stock price fell over 20% on May 16, 2025.
If you suffered a loss on your Travere Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Schrdinger, Inc. (NASDAQ: SDGR) concerning potential violations of the federal securities laws.
Schrödinger issued a press release on May 20, 2025, “announcing that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial officer to pursue other opportunities.”
Following this news, Schrödinger’s stock price fell over 8% on the same day.
If you suffered a loss on your Schrdinger, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Meta Platforms, Inc. (NASDAQ: META) concerning potential violations of the federal securities laws.
The Wall Street Journal published an article on May 15, 2025, entitled "Meta Is Delaying the Rollout of Its Flagship AI Model." Citing "people familiar with the matter", the article reported, in relevant part, that "[c]ompany engineers are struggling to significantly improve the capabilities of its "Behemoth" large-language model, leading to staff questions about whether the improvements over prior versions are significant enough to justify public release[.]" The article further reported that while originally "Behemoth was internally slated for an April release", Meta subsequently "pushed an internal target for . . . Behemoth's release to June" before "delay[ing] . . . to fall or later." Following this news, Meta's stock price fell over 2% on May 16, 2025.
If you suffered a loss on your Meta Platforms, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Coinbase Global, Inc. (NASDAQ: COIN) concerning potential violations of the federal securities laws.
Coinbase Chief Executive Officer Brian Armstrong announced in a social media post on May 15, 2025, that criminals had improperly obtained personal data on the exchange's customers for use in crypto-stealing scams and were demanding a $20 million payment not to publicly release the information. Armstrong said that criminals had obtained the data by bribing Coinbase customer service agents. Following this news, Coinbase's stock price fell sharply during intraday trading on the same day.
If you suffered a loss on your Coinbase Global, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Luminar Technologies, Inc. (NASDAQ: LAZR) concerning potential violations of the federal securities laws.
Luminar issued a press release on May 14, 2025, announcing "the resignation of founder Austin Russell as President and CEO of the company and as the Chairperson of the Board, effective immediately, following a Code of Business Conduct and Ethics inquiry by the Audit Committee of the Board of Directors." Following this news, Luminar's stock price fell over 16% on May 15, 2025.
If you suffered a loss on your Luminar Technologies, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into EchoStar Corporation (NASDAQ: SATS) concerning potential violations of the federal securities laws.
The Wall Street Journal reported on May 12, 2025, that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network. Following this news, EchosStar stock dropped heavily on the same day.
If you suffered a loss on your EchoStar Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Flowco Holdings Inc. (NYSE: FLOC) concerning potential violations of the federal securities laws.
On May 13, 2025, Flowco issued a press release reporting its financial results for the first quarter of 2025. Among other items, Flowco reported revenue of $192.4 million, missing consensus estimates by $6.26 million, and GAAP earning per share of $0.24, missing consensus estimates by $0.06. In its press release, Flowco said that "the U.S. upstream outlook has been challenged by evolving tariff policies, OPEC+ commentary suggesting accelerated production, and broader economic uncertainty." Following this news, Flowco's stock price fell over 12% on May 13, 2025.
If you suffered a loss on your Flowco Holdings Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Legend Biotech Corporation (NASDAQ: LEGN) concerning potential violations of the federal securities laws.
On May 13, 2024, Legend published first quarter financial results and business updates, including, among other things, news that the Company is navigating regulatory challenges, such as the need for FDA approval for the expansion of its Raritan manufacturing facility. Legend also detailed its struggles with improving manufacturing turnaround times, as well as concerns surrounding the US and non-US price differentials and its ability to penetrate the community settings for its pharmaceutical treatments. Analysts responded to the news with lowered price targets. Following this news, Legend’s stock price fell over 10% to close at $27.80 per share on May 14, 2025.
If you suffered a loss on your Legend Biotech Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Globus Medical, Inc. (NYSE: GMED) concerning potential violations of the federal securities laws.
Globus issued a press release reporting its financial results for the first quarter of 2025 On May 8, 2025. Among other items, Globus reported non-GAAP earnings per share of $0.68, missing consensus estimates by $0.06, and revenue of $598.12 million, missing consensus estimates by $27.78 million and representing a 1.4% year-over-year decline. Globus’s President and Chief Executive Officer said that the Company’s “first quarter results were impacted by softer Enabling Technology deal closures, temporary integration related supply chain disruption, and timing of international distributor orders[.]” Following this news, Globus’s stock price fell over 22% on May 9, 2025.
If you suffered a loss on your Globus Medical, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Metallus Inc. (NYSE: MTUS) concerning potential violations of the federal securities laws.
Metallus issued a press release announcing its financial results for the first quarter of 2025 on May 8, 2025. Among other items, Metallus reported non-GAAP earnings per share of $0.07, missing consensus estimates by $0.05. Metallus’s Chief Executive Officer said that the Company had “seen some volatility in the defense supply chain during the first quarter driven by customer manufacturing start-up challenges.” Following this news, Metallus’s stock price fell over 11% on May 9, 2025.
If you suffered a loss on your Metallus Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Myriad Genetics, Inc. (NASDAQ: MYGN) concerning potential violations of the federal securities laws.
Myriad released its first quarter 2025 financial results on May 6, 2025, revealing "revenue of $196 million declined by 3% year-over-year" and "pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reducing coverage of GeneSight®." Additionally, the Company announced reduced financial guidance for 2025 "reflecting first quarter 2025 results and the current business outlook." Following this news, Myriad stock dropped on heavy trading volume on that day.
If you suffered a loss on your Myriad Genetics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Ichor Holdings, Ltd. (NASDAQ: ICHR) concerning potential violations of the federal securities laws.
Ichor released its first-quarter 2025 financial results on May 5, 2025, missing EPS and revenue consensus estimates, and reporting a gross margin of 12.4%, which is below the forecasted midpoint of 14.5%. Ichor stated "In Q1, our strategy did not materialize into the margin flow through we anticipated, essentially because we ended up purchasing far more external supply than we had forecasted." Following this news, Ichor stock dropped heavily the same day.
If you suffered a loss on your Ichor Holdings, Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into nCino, Inc. (NASDAQ: NCNO) concerning potential violations of the federal securities laws.
On April 1, 2025, nCino reported positive 4Q 2025 financial results but announced fiscal 2026 guidance that was below analysts’ expectations. Management attributed the lowered guidance to declining subscription revenue growth and “softer-than-expected sales execution” in Europe. Following this news, NCNO’s stock price fell by $5.53 per share, or approximately 20%, to close at $22.59 per share.
If you suffered a loss on your nCino, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





